Outcome at 10 years of severe vesicoureteric reflux managed medically: Report of the International Reflux Study in Children
- PMID: 11713442
- DOI: 10.1067/mpd.2001.117583
Outcome at 10 years of severe vesicoureteric reflux managed medically: Report of the International Reflux Study in Children
Abstract
Objective: To study the progress of vesicoureteric reflux (VUR) grade III or IV in children followed up prospectively over 10 years.
Study design: One hundred forty-nine children (33 boys and 116 girls) with VUR were recruited for the International Reflux Study in Children and were treated with a medical regimen and monitored by means of serial cystograms. VUR disappearance was based on negative findings on 2 consecutive cystograms.
Results: At 5 years, VUR with dilatation was seen in 72 (48%) children and VUR without dilatation, in 55 (37%); 22 (15%) children had no reflux. At 10 years, VUR with dilatation was seen in 34 (23%) children and VUR without dilatation, in 37 (25%); 78 (52%) children had no reflux. Grade IV VUR persisted in 8 children. Absence of VUR was significantly associated with grade III versus grade IV VUR (P = .007), unilateral versus bilateral reflux (P = .0002), and age > or = 5 years at entry versus age < 5 years (P = .001). Neither sex nor renal scarring at entry individually affected resolution of VUR. Among 43 (29%) children with intermittent VUR, only 6 had reflux with dilatation at 10 years.
Conclusion: Continuing reduction in the severity of VUR in children receiving careful medical treatment was observed over 10 years. On the basis of negative findings on 2 consecutive cystograms, VUR was absent in half of the children.
Comment in
-
Vesicoureteral reflux and evidence-based management.J Pediatr. 2001 Nov;139(5):620-1. doi: 10.1067/mpd.2001.119451. J Pediatr. 2001. PMID: 11713435 No abstract available.
-
Outcome at 10 years of severe vesicoureteric reflux managed medically: Report of the International Reflux Study in Children.J Urol. 2003 Jul;170(1):323-24. J Urol. 2003. PMID: 14567322 No abstract available.
Similar articles
-
Outcome of conservative treatment of primary vesicoureteral reflux in 87 Thai children in a single center.Int J Urol. 2006 Nov;13(11):1393-7. doi: 10.1111/j.1442-2042.2006.01588.x. Int J Urol. 2006. PMID: 17083390
-
[Endoscopic treatment of vesicoureteric reflux (VUR) in children: results of 9 years of use of Macroplastique (polydimethylsiloxane)].Prog Urol. 2003 Dec;13(6):1368-71. Prog Urol. 2003. PMID: 15000316 French.
-
[Success of endoscopic management in vesicoureteral reflux, conditioned by ureteral dilatation].Cir Pediatr. 2003 Apr;16(2):90-4. Cir Pediatr. 2003. PMID: 13677102 Spanish.
-
Vesicoureteric reflux (VUR) in children: where are we now?Arch Esp Urol. 2012 May;65(4):450-8. Arch Esp Urol. 2012. PMID: 22619135 Review. English, Spanish.
-
[Endoscopic and conservative treatment of vesicoureteric reflux].Cas Lek Cesk. 2007;146(10):817-21. Cas Lek Cesk. 2007. PMID: 18020019 Review. Czech.
Cited by
-
Utility of ureteral diameter ratio for clinical decision-making in children with vesicoureteral reflux: a systematic review and meta analysis.Pediatr Surg Int. 2024 Nov 7;40(1):296. doi: 10.1007/s00383-024-05885-9. Pediatr Surg Int. 2024. PMID: 39508876 Review.
-
Congenital Anomalies of the Kidney and Urinary Tract: A Clinical Review.Curr Treat Options Pediatr. 2019;5(3):223-235. doi: 10.1007/s40746-019-00166-3. Epub 2019 Jun 11. Curr Treat Options Pediatr. 2019. PMID: 32864297 Free PMC article.
-
Interventions for primary vesicoureteric reflux.Cochrane Database Syst Rev. 2019 Feb 20;2(2):CD001532. doi: 10.1002/14651858.CD001532.pub5. Cochrane Database Syst Rev. 2019. PMID: 30784039 Free PMC article.
-
Predicting long-term renal damage in children with vesicoureteral reflux under conservative initial management: 205 cases in a tertiary referral center.Cent European J Urol. 2018;71(1):142-147. doi: 10.5173/ceju.2018.1513. Epub 2017 Jan 29. Cent European J Urol. 2018. PMID: 29732221 Free PMC article.
-
The treatment of vesicoureteral reflux in children by endoscopic sub-mucosal intra-ureteral injection of dextranomer/hyaluronic acid: A case-series, multi-centre study.Electron Physician. 2017 Apr 25;9(4):4145-4149. doi: 10.19082/4145. eCollection 2017 Apr. Electron Physician. 2017. PMID: 28607648 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
